SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (29011)6/29/1999 11:17:00 PM
From: WTDEC  Respond to of 32384
 
Heny, our posts crossed in the network..>)

Walter



To: Henry Niman who wrote (29011)6/29/1999 11:32:00 PM
From: WTDEC  Read Replies (1) | Respond to of 32384
 
Henry, Domaine is a leading venture firm with a focus on lifesciences. They are highly regarded in the business. I hope the market recognizes that the fact that Domaine was willing to get involved is yet another validation of LGND's preeminence in IRs.

I believe the financing is a major coup for LGND in an extremely difficult environment for raising capital. Very exciting, IMO.

Regards,

Walter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News